Multiple Myeloma
Multiple myeloma is a type of cancer that forms in plasma cells, a kind of white blood cell responsible for producing antibodies. It can lead to various health issues, including bone pain and anemia.
Multiple Myeloma: TG01/QS-21 Vaccine Study
We are investigating a new vaccine for patients with specific genetic mutations in multiple myeloma. The study aims to evaluate its safety and effectiveness in those at high risk or with measurable disease.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Oslo University Hospital Hf
Hematology
Oslo, Norway
Sponsor: Oslo University Hospital Hf
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.